SERGIO SCHWARTZMAN M.D.
Prescription History 1841225521
Internal Medicine - Rheumatology in New York, NY
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for SERGIO SCHWARTZMAN M.D., an active Rheumatology specialist practicing in New York, NY. Our medical registry currently tracks 9 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 228 documented patient claims. Among these therapy options, the most frequently utilized medication is Methylprednisolone, which accounts for 41 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2023)Rx (2023) | Avg Cost per FillCost / Fill | Vs. Other NY PrescribersVs. NY Avg |
|---|---|---|---|
| Methylprednisolone | 41 | $33.19 | ▲ More than typical |
About Methylprednisolone: Methylprednisolone is used to treat conditions such as arthritis, blood disorders, severe allergic reactions, certain cancers, eye conditions, skin/kidney/intestinal/lung diseases, and immune system disorders. Show more ▾ It decreases your immune system's response to various diseases to reduce symptoms such as swelling, pain, and allergic-type reactions. This medication is a corticosteroid hormone. Methylprednisolone may also be used with other medications in hormone disorders. A PREDNISOLONE derivative with similar anti-inflammatory action. In 2023, this provider wrote 41 Medicare prescriptions for Methylprednisolone, about 1.3 times the volume of the typical New York prescriber of this medication (32). Medicare paid an average of $33.19 per fill, versus $11.18 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 62.3 30-Day Fills standardized to 30-day supplies 1,537 Days of Medication total across all patients in 2023 | |||
| Prednisone | 36 | $26.30 | ≈ Typical |
About Prednisone: Prednisone is used to treat conditions such as arthritis, blood disorders, breathing problems, severe allergies, skin diseases, cancer, eye problems, and immune system disorders. Show more ▾ Prednisone belongs to a class of drugs known as corticosteroids. It decreases your immune system's response to various diseases to reduce symptoms such as swelling and allergic-type reactions. A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver. In 2023, this provider wrote 36 Medicare prescriptions for Prednisone, about 82% of the volume of the typical New York prescriber of this medication (44). Medicare paid an average of $26.30 per fill, versus $6.20 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 94.2 30-Day Fills standardized to 30-day supplies 2,827 Days of Medication total across all patients in 2023 | |||
| Taltz AutoinjectorIxekizumab | 36 | $7,527.74▼ below NY avg | ▲ More than typical |
About Taltz Autoinjector: This medication is used to treat plaque psoriasis and certain types of arthritis (psoriatic arthritis, ankylosing spondylitis, axial spondyloarthritis). Show more ▾ Ixekizumab belongs to a class of drugs known as monoclonal antibodies. It works by blocking a certain natural protein in your body (interleukin-17A) that may cause inflammation and swelling. In 2023, this provider wrote 36 Medicare prescriptions for Taltz Autoinjector, about 2.1 times the volume of the typical New York prescriber of this medication (17). Medicare paid an average of $7,527.74 per fill, versus $7,932.67 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 36 30-Day Fills standardized to 30-day supplies 1,008 Days of Medication total across all patients in 2023 | |||
| Hydroxychloroquine Sulfate | 33 | $65.80▼ below NY avg | ▼ Less than typical |
About Hydroxychloroquine Sulfate: Hydroxychloroquine is used to prevent or treat malaria caused by mosquito bites. Show more ▾ The United States Center for Disease Control provides updated guidelines and travel recommendations for the prevention and treatment of malaria in different parts of the world. Discuss the most recent information with your doctor before traveling to areas where malaria occurs. This medication is also used to treat certain auto-immune diseases (lupus, rheumatoid arthritis). It belongs to a class of medications known as disease-modifying antirheumatic drugs (DMARDs). It can reduce skin problems in lupus and prevent swelling/pain in arthritis. Hydroxychloroquine is not recommended for coronavirus infection, also known as COVID-19, unless you are enrolled in a study. Talk to your doctor about the risks and benefits. A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970) In 2023, this provider wrote 33 Medicare prescriptions for Hydroxychloroquine Sulfate, about a third of the volume of the typical New York prescriber of this medication (82). Medicare paid an average of $65.80 per fill, versus $66.53 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 84.8 30-Day Fills standardized to 30-day supplies 2,495 Days of Medication total across all patients in 2023 | |||
| Meloxicam | 22 | $12.66 | ▼ Less than typical |
About Meloxicam: Meloxicam is used to help relieve moderate to severe pain. Show more ▾ Meloxicam is known as a nonsteroidal anti-inflammatory drug (NSAID). It works by blocking your body's production of certain natural substances that cause inflammation. This effect helps to decrease swelling or pain. A benzothiazine and thiazole derivative that acts as a NSAID and cyclooxygenase-2 (COX-2) inhibitor. It is used in the treatment of RHEUMATOID ARTHRITIS; OSTEOARTHRITIS; and ANKYLOSING SPONDYLITIS. In 2023, this provider wrote 22 Medicare prescriptions for Meloxicam, about half the volume of the typical New York prescriber of this medication (48). Medicare paid an average of $12.66 per fill, versus $5.53 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 55.5 30-Day Fills standardized to 30-day supplies 1,665 Days of Medication total across all patients in 2023 | |||
| MethotrexateMethotrexate Sodium | 17 | $11.75▼ below NY avg | ▼ Less than typical |
About Methotrexate: Methotrexate is used to treat certain types of cancer (such as acute lymphoblastic leukemia, non-Hodgkin's lymphoma) or to control severe psoriasis or rheumatoid arthritis that has not responded to other treatments. Show more ▾ It may also be used to control juvenile rheumatoid arthritis. Methotrexate belongs to a class of drugs known as antimetabolites. It works by slowing or stopping the growth of cancer cells and suppressing the immune system. Early treatment of rheumatoid arthritis with more aggressive therapy such as methotrexate helps to reduce further joint damage and to preserve joint function. An antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of TETRAHYDROFOLATE DEHYDROGENASE and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA. In 2023, this provider wrote 17 Medicare prescriptions for Methotrexate, about 19% of the volume of the typical New York prescriber of this medication (88). Medicare paid an average of $11.75 per fill, versus $38.80 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 31.8 30-Day Fills standardized to 30-day supplies 942 Days of Medication total across all patients in 2023 | |||
| Orencia ClickjectAbatacept | 16 | $7,676.53 | ▼ Less than typical |
About Orencia Clickject: This medication is used to treat rheumatoid arthritis, a condition in which the body's own defense system (immune system) attacks healthy tissue. Show more ▾ This leads to swelling in the joints, which causes pain and makes it harder to move. Abatacept works by weakening your immune system. This effect helps to slow down joint damage and reduce joint pain and swelling so you can move better. This medication is also used to treat other types of arthritis (such as juvenile idiopathic arthritis, psoriatic arthritis). A fusion protein immunoconjugate of the extracellular domain of CTLA4 and the Fc domain of human IgG1. It functions as a T-cell co-stimulation blocker that inhibits TNF-ALPHA and prevents the activation of T-LYMPHOCYTES. It is used in the treatment of RHEUMATOID ARTHRITIS. In 2023, this provider wrote 16 Medicare prescriptions for Orencia Clickject, about 73% of the volume of the typical New York prescriber of this medication (22). Medicare paid an average of $7,676.53 per fill, versus $5,828.81 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 21.4 30-Day Fills standardized to 30-day supplies 616 Days of Medication total across all patients in 2023 | |||
| Mycophenolate Mofetil | 15 | $111.79▼ below NY avg | ▼ Less than typical |
About Mycophenolate Mofetil: Mycophenolate is used in combination with other medications to keep your body from attacking and rejecting your transplanted organ (such as kidney, liver, heart). Show more ▾ It belongs to a class of medications called immunosuppressants. It works by weakening your body's defense system (immune system) to help your body accept the new organ as if it were your own. Compound derived from Penicillium stoloniferum and related species. It blocks de novo biosynthesis of purine nucleotides by inhibition of the enzyme inosine monophosphate dehydrogenase (IMP DEHYDROGENASE). Mycophenolic acid exerts selective effects on the immune system in which it prevents the proliferation of T-CELLS, LYMPHOCYTES, and the formation of antibodies from B-CELLS. It may also inhibit recruitment of LEUKOCYTES to sites of INFLAMMATION. In 2023, this provider wrote 15 Medicare prescriptions for Mycophenolate Mofetil, about half the volume of the typical New York prescriber of this medication (28). Medicare paid an average of $111.79 per fill, versus $148.11 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 20.8 30-Day Fills standardized to 30-day supplies 621 Days of Medication total across all patients in 2023 | |||
| KineretAnakinra | 12 | $5,209.24 | ≈ Typical |
About Kineret: Anakinra is used to treat rheumatoid arthritis. Show more ▾ It helps to slow joint damage and reduces the joint pain/swelling so that you can move better. It is also used to treat a condition called Neonatal-Onset Multisystem Inflammatory Disease (NOMID). It helps to improve symptoms of the disease such as fever, rash, joint pain, vomiting, and headache. Anakinra may also be used to treat another condition called Deficiency of Interleukin-1 Receptor Antagonist (DIRA), a condition where your body does not produce the natural protein interleukin-1 receptor antagonist. Anakinra is a man-made form of a natural protein (interleukin-1 receptor antagonist) made by the body. It helps to block the effects of another protein (interleukin-1) which can cause symptoms such as joint pain/swelling/stiffness. The FDA is allowing the emergency use of anakinra to treat coronavirus disease (COVID-19) in hospitalized patients with pneumonia and who also need supplemental oxygen. If anakinra is used to treat coronavirus disease, more information about the drug is available from the patient information sheet provided by your health care professional. A ligand that binds to but fails to activate the INTERLEUKIN 1 RECEPTOR. It plays an inhibitory role in the regulation of INFLAMMATION and FEVER. Several isoforms of the protein exist due to multiple ALTERNATIVE SPLICING of its mRNA. In 2023, this provider wrote 12 Medicare prescriptions for Kineret, about 86% of the volume of the typical New York prescriber of this medication (14). Medicare paid an average of $5,209.24 per fill, versus $5,190.48 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 12 30-Day Fills standardized to 30-day supplies 336 Days of Medication total across all patients in 2023 | |||
About this data. The prescription history for SERGIO SCHWARTZMAN M.D. is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2023, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Rheumatology prescribing approach at this New York, NY practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average volume among NY prescribers of the same medication. Always confirm current medications and costs directly with the provider and your plan.
